Biorepository opens in Germany; Forget spare capacity;

> Indianapolis-based BioStorage Technologies is expanding its European operations with the opening of 1,500-square-meter full-service biorepository in Frankfurt.

> Drug makers must move away from their traditional inclination to retain spare capacity and inventory. Article

> World Courier has opened investigational drug storage facilities in Melbourne, Australia, and Johannesburg, South Africa, bringing its network of GMP-compliant clinical trial depots to 11 worldwide. Release

> A patient-centered regulatory and policymaking approach is the objective of an anticounterfeiting effort in Ghana. Release

> Patheon will manufacture clinical supplies of a sustained-release opioid analgesic candidate for QRxPharma of Australia. Announcement

Suggested Articles

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.